Sakar Healthcare Limited (SAKAR) — Financial Results | 20 July 2026
Sakar Healthcare Limited announced a board meeting on 24 July 2026 to approve unaudited financial results for the quarter ended 30 June 2026, with trading window restrictions applying until 48 hours post-results announcement.
About Sakar Healthcare Limited (SAKAR)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when SAKAR files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SAKAR — Free💡 Ask AI about this filing
📊 More SAKAR filings
- 🔴 Financial Results — 28 July 2026 Sakar Healthcare Limited reported Q1FY27 consolidated revenue of ₹7,297 lakhs, up 38% YoY, driven by...
- Announcement — 24 July 2026 Sakar Healthcare Limited announced a conference call on July 29, 2026, at 12:00 PM IST to discuss Q1...
- 🟡 Board Meeting — 24 July 2026 Sakar Healthcare announced the outcome of its board meeting on 24th July 2026, approving unaudited f...
- 🔴 Financial Results — 24 July 2026 Sakar Healthcare reported consolidated revenue of **₹7,297 crores** for Q1FY27, up 38% YoY, driven b...
- Financial Results — 26 June 2026 Sakar Healthcare Limited announced that its trading window will close on 1st July 2026 and remain cl...
🔥 Also filed on 20 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SAKAR files new disclosures
Track SAKAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SAKAR — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research